N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide

Term ID

CHEBI:27731

Synonyms

(Gal)1 (GalNAc)1 (Glc)1 (Cer)1
a ganglioside GA2 (d18:1(4E))
asialo GM2
Asialo GM2-re-N-acetylated
asialoganglioside GM2
beta-D-GalpNAc-(1->4)-beta-D-Galp-(1->4)-beta-D-Glcp-(1<->1')-Cer
GA2
GalNAc-beta1->4Gal-beta1->4Glc-beta1->1'Cer
GalNAc-beta1->4LacCer
GgOSe3Cer
N-[(2S,3R,4E)-1-{[2-acetamido-2-deoxy-beta-D-galactopyranosyl-(1->4)-beta-D-galactopyranosyl-(1->4)-beta-D-glucopyranosyl]oxy}-3-hydroxyoctadec-4-en-2-yl]alkanamide
N-acetyl-beta-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramides

(all 12)

Definition

A glycotriaosylceramide having N-acetyl-beta-D-galactosyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl as the triaosyl component.

References

(all 16)

Ontology

ChEBI ( EBI )

Relationships

is a type of: glycotriaosylceramide N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-Cer N-acetylhexosaminyl-dihexosylceramide

glycotriaosylceramide N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-Cer N-acetylhexosaminyl-dihexosylceramide Show first 5 Terms
has subtype: N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-stearoylsphingosine

N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-N-stearoylsphingosine Show first 5 Terms
has_part: beta-D-GalNAc-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-yl group

beta-D-GalNAc-(1->4)-beta-D-Gal-(1->4)-beta-D-Glc-yl group Show first 5 Terms
has_role: mouse metabolite

mouse metabolite Show first 5 Terms

Phenotype

Phenotype resulting from N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide

Phenotype where environments contain N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide

Phenotype modified by environments containing N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide

Phenotype affecting N-acetyl-beta-D-galactosaminyl-(1->4)-beta-D-galactosyl-(1->4)-beta-D-glucosylceramide

Human Disease Model